![Lone Veng](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lone Veng
Nessuna posizione attualmente
Profilo
Lone Veng was the Chief Executive Officer at ResoTher Pharma AS.
Precedenti posizioni note di Lone Veng
Società | Posizione | Fine |
---|---|---|
ResoTher Pharma AS
![]() ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Amministratore Delegato | 01/02/2023 |
Esperienze
Posizioni ricoperte
Società collegate
Aziende private | 1 |
---|---|
ResoTher Pharma AS
![]() ResoTher Pharma AS Pharmaceuticals: MajorHealth Technology ResoTher Pharma is a privately held clinical-stage biotech company based in Copenhagen, Denmark. ResoTher Pharma focuses on developing compounds that induce inflammatory resolution in cardiovascular diseases. The Danish company's lead compound, RTP-026, has shown to have a profound effect on reducing infarction size and restoring cardiac function to a pre-infarction level. ResoTher Pharma's mission is to create novel medicines that benefit patients in need by addressing unmet needs in CVD inflammation through endogenous immune regulatory pathways. The company was founded in 2016 by Thomas Jonassen and is privately owned by a group of prominent Danish investors. | Health Technology |
- Borsa valori
- Insiders
- Lone Veng